The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2022
DOI: 10.2147/jaa.s324080
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Defective Epithelial Barriers in Allergic Lung Disease and Asthma Development

Abstract: The respiratory epithelium constitutes the physical barrier between the human body and the environment, thus providing functional and immunological protection. It is often exposed to allergens, microbial substances, pathogens, pollutants, and environmental toxins, which lead to dysregulation of the epithelial barrier and result in the chronic inflammation seen in allergic diseases and asthma. This epithelial barrier dysfunction results from the disturbed tight junction formation, which are multi-protein subuni… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
19
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(22 citation statements)
references
References 223 publications
1
19
1
Order By: Relevance
“…Mouse model of asthma is characterized with AAI developed with i.p OVA sensitization and i.n challenge with OVA in BALB/c mice. This model is characterized by airway inflammation associated with increased type 2 lymphocytes infiltration, eosinophils, alveolar epithelial barrier damage, and mucus secretion by epithelial goblet cells, [2,15,16,32,33] however, the inflammatory manifestations in the gut in not well studied. As observed in several previous studies highlighted the importance of Th2 responses in both gut and lung, we first intend to observe the type of inflammation in the gut and lung at prechallenge and post-challenge conditions during the development of AAI in mouse model of asthma.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Mouse model of asthma is characterized with AAI developed with i.p OVA sensitization and i.n challenge with OVA in BALB/c mice. This model is characterized by airway inflammation associated with increased type 2 lymphocytes infiltration, eosinophils, alveolar epithelial barrier damage, and mucus secretion by epithelial goblet cells, [2,15,16,32,33] however, the inflammatory manifestations in the gut in not well studied. As observed in several previous studies highlighted the importance of Th2 responses in both gut and lung, we first intend to observe the type of inflammation in the gut and lung at prechallenge and post-challenge conditions during the development of AAI in mouse model of asthma.…”
Section: Discussionmentioning
confidence: 99%
“…Type 2 inflammation is known to induce epithelial barrier damage in the gut and lungs. [16,[44][45][46] In UC, IL-13 is observed as a key effector cytokine in inducing intestinal epithelial barrier dysfunction promoting distinct pathogenesis of Th2-driven intestinal inflammation. [47,48] Previous observations in vitro showed epithelial apoptosis and reduced claudin expression mediated by STAT6-activated IL-13 in patients with UC.…”
Section: Discussionmentioning
confidence: 99%
“…Keratin, a member of fibrous structural proteins, can protect epithelial cells from stress and damage [ 27 ]. Disruption of epithelial barrier function, such as cornification or keratinization, might result in allergic diseases [ 28 ]. Inoue et al find that downregulation of epithelial defense genes and keratinization occurs in SA mouse sensitized by Alternaria [ 29 ].…”
Section: Discussionmentioning
confidence: 99%
“…Mucosal surface integrity and mucus secretion in the eye and nose, the upper respiratory tract, the gastrointestinal tract (GIT), and the urogenital tract are critical to impede diffusion and mediate elimination of invaded pollutants. Dysfunctional mucosal epithelial barriers have been associated with antigen invasion, inflammatory activation of epithelial cells, and allergic reactions leading to the development of allergic diseases [11,12]. The GIT that is exposed to the external environment through ingested particles taken up by diet, inhalation, or other interventions exhibits a barrier formed by tightly connected epithelial cells lined with mucus and microbiota.…”
Section: Mucosal Tissue Exposurementioning
confidence: 99%